about
Viral load as a surrogate end point in HIV disease.The emerging role of MRI in multiple sclerosis and the new diagnostic criteria.The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs.Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholdersSurrogate markers for time-varying treatments and outcomes
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Surrogate markers in HIV disease.
@en
type
label
Surrogate markers in HIV disease.
@en
prefLabel
Surrogate markers in HIV disease.
@en
P356
P1476
Surrogate markers in HIV disease.
@en
P2093
P304
P356
10.1093/JAC/37.SUPPL_B.161
P407
P478
37 Suppl B
P577
1996-05-01T00:00:00Z